HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Niel, F. Articles by Valleix, S. Search for Related Content PubMed PubMed Citation Articles by Niel, F. Articles by Valleix, S.

Truncating Mutations in the Carbohydrate Sulfotransferase 6 Gene (CHST6) Result in Macular Corneal Dystrophy

¹From the Laboratory of Biochemistry and Molecular Genetics, Hospital, Cochin, Paris, France; the ²Department of Ophthalmology, Hospital Hôtel-Dieu, Paris, France; the ³Department of Ophthalmology, Hospital of Poitiers, France; and the ⁴Laboratory of Biochemistry A, Hospital, Hôtel-Dieu, Paris, France.

PURPOSE. Identification of mutations in the CHST6 gene in 15 patients from 11 unrelated families affected with recessive macular corneal dystrophy (MCD).

METHODS. Genomic DNA was extracted from peripheral blood leukocytes of the affected patients and their healthy family members, and the mutational status of the CHST6 gene was determined for each patient by a PCR-sequencing approach. Serum concentrations of antigenic keratan sulfate for each proband were determined by ELISA.

RESULTS. ELISA indicated that all affected patients, except one, were of MCD type I or IA. Fourteen distinct mutations were identified within the CHST6 coding region: 2 nonsense, 2 frameshift, and 10 missense. Of these, 12 were novel, and a nonsense mutation in the homozygous state is reported for the first time.

CONCLUSIONS. These molecular results in French patients with MCD combined with those reported in previous studies indicated CHST6 mutational heterogeneity. The characterization herein of nonsense mutations is in keeping with the fact that MCD results from loss of function of the CHST6 protein product.

This article has been cited by other articles:

				P Liskova, B Veraitch, K Jirsova, M Filipec, A Neuwirth, N D Ebenezer, P G Hysi, A J Hardcastle, S J Tuft, and S S Bhattacharya Sequencing of the CHST6 gene in Czech macular corneal dystrophy patients supports the evidence of a founder mutation Br. J. Ophthalmol., February 1, 2008; 92(2): 265 - 267. [Abstract] [Full Text] [PDF]

				A. J. Aldave and B. Sonmez Elucidating the Molecular Genetic Basis of the Corneal Dystrophies: Are We There Yet? Arch Ophthalmol, February 1, 2007; 125(2): 177 - 186. [Abstract] [Full Text] [PDF]